Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone for Emotional Blunting in Major Depressive Disorder
NCT07824206Phase 4Not yet recruiting
- Sponsor
- Future Options Research
- Start
- Sep 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 4 trial of lumateperone in major depressive disorder (MDD), sponsored by Future Options Research. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
lumateperone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07824206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824206.